Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses.
Fidanza M, Seif AE, DeMicco A, Rolf N, Jo S, Yin B, Li Y, Barrett DM, Duque-Afonso J, Cleary ML, Bassing CH, Grupp SA, Reid GS.
Fidanza M, et al.
Leukemia. 2016 Oct;30(10):2116-2119. doi: 10.1038/leu.2016.152. Epub 2016 May 25.
Leukemia. 2016.
PMID: 27220664
Free PMC article.
No abstract available.